Gomez-Navarro J - Search Results

1

An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites.

Barker SD, Casado E, Gomez-Navarro J, Xiang J, Arafat W, Mahasreshti P, Pustilnik TB, Hemminki A, Siegal GP, Alvarez RD, Curiel DT. Barker SD, et al. Gynecol Oncol. 2001 Jul;82(1):57-63. doi: 10.1006/gyno.2001.6226. Gynecol Oncol. 2001. PMID: 11426962

2

An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches.

Vanderkwaak TJ, Wang M, Gómez-Navarro J, Rancourt C, Dmitriev I, Krasnykh V, Barnes M, Siegal GP, Alvarez R, Curiel DT. Vanderkwaak TJ, et al. Gynecol Oncol. 1999 Aug;74(2):227-34. doi: 10.1006/gyno.1999.5432. Gynecol Oncol. 1999. PMID: 10419736

3

Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications.

Casado E, Gomez-Navarro J, Yamamoto M, Adachi Y, Coolidge CJ, Arafat WO, Barker SD, Wang MH, Mahasreshti PJ, Hemminki A, Gonzalez-Baron M, Barnes MN, Pustilnik TB, Siegal GP, Alvarez RD, Curiel DT. Casado E, et al. Clin Cancer Res. 2001 Aug;7(8):2496-504. Clin Cancer Res. 2001. PMID: 11489832

4

Transcriptional targeting for ovarian cancer gene therapy.

Casado E, Nettelbeck DM, Gomez-Navarro J, Hemminki A, Gonzalez Baron M, Siegal GP, Barnes MN, Alvarez RD, Curiel DT. Casado E, et al. Gynecol Oncol. 2001 Aug;82(2):229-37. doi: 10.1006/gyno.2001.6305. Gynecol Oncol. 2001. PMID: 11531272 Review.

5

Bax-induced apoptosis as a novel gene therapy approach for carcinoma of the cervix.

Huh WK, Gomez-Navarro J, Arafat WO, Xiang J, Mahasreshti PJ, Alvarez RD, Barnes MN, Curiel DT. Huh WK, et al. Gynecol Oncol. 2001 Nov;83(2):370-7. doi: 10.1006/gyno.2001.6403. Gynecol Oncol. 2001. PMID: 11606099

6

Selectivity of TAG-72-targeted adenovirus gene transfer to primary ovarian carcinoma cells versus autologous mesothelial cells in vitro.

Kelly FJ, Miller CR, Buchsbaum DJ, Gomez-Navarro J, Barnes MN, Alvarez RD, Curiel DT. Kelly FJ, et al. Clin Cancer Res. 2000 Nov;6(11):4323-33. Clin Cancer Res. 2000. PMID: 11106250

7

Gene therapy: ovarian carcinoma as the paradigm.

Gómez-Navarro J, Siegal GP, Alvarez RD, Curiel DT. Gómez-Navarro J, et al. Am J Clin Pathol. 1998 Apr;109(4):444-67. doi: 10.1093/ajcp/109.4.444. Am J Clin Pathol. 1998. PMID: 9535399 Review.

8

Modulation of Bcl-2 protein levels by an intracellular anti-Bcl-2 single-chain antibody increases drug-induced cytotoxicity in the breast cancer cell line MCF-7.

Piché A, Grim J, Rancourt C, Gómez-Navarro J, Reed JC, Curiel DT. Piché A, et al. Cancer Res. 1998 May 15;58(10):2134-40. Cancer Res. 1998. PMID: 9605757

9

Interleukin-6 modulated conditionally replicative adenovirus as an antitumor/cytotoxic agent for cancer therapy.

Rancourt C, Piché A, Gomez-Navarro J, Wang M, Alvarez RD, Siegal GP, Fuller GM, Jones SA, Curiel DT. Rancourt C, et al. Clin Cancer Res. 1999 Jan;5(1):43-50. Clin Cancer Res. 1999. PMID: 9918201

10

Targeted adenoviral vectors for cancer gene therapy.

Bilbao G, Gómez-Navarro J, Curiel DT. Bilbao G, et al. Adv Exp Med Biol. 1998;451:365-74. doi: 10.1007/978-1-4615-5357-1_57. Adv Exp Med Biol. 1998. PMID: 10026898 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters